MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Health Systems, Economic Evaluations, Quality of Life
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

6,862 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
6,862 works in the cohort · of 4,299,418page 3 of 138

Labels cover 97 of 6,862 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 6,862 of 6,862 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affaboutunlabeled
Health-State Utilities and Quality of Life in Hepatitis C Patients
Christopher Chong, Anar Gulamhussein, E. Jenny Heathcote, Les Lilly, Morris Sherman, Gary Naglie +1 more
2003· article· en· The American Journal of Gastroenterology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
274
citations
affunlabeled
Adverse Outcome Pathway Development II: Best Practices
Daniel L. Villeneuve, Doug Crump, Natàlia García‐Reyero, Markus Hecker, Thomas H. Hutchinson, Carlie A. LaLone +7 more
2014· article· en· Toxicological Sciences· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
257
citations
affunlabeled
The GRADE approach and Bradford Hill's criteria for causation
Holger J. Schünemann, Suzanne Hill, Gordon Guyatt, Elie A. Akl, Faruque Ahmed
2010· article· en· Journal of Epidemiology & Community Health· Economics, Econometrics and Finance
machine prediction:candidate · metaresearchconsensus · metaresearch
257
citations
affvenueno abstractunlabeled
A review of the cost of cardiovascular disease
Jean‐Éric Tarride, Morgan Lim, Marie DesMeules, Wei Luo, Natasha Burke, Daria O’Reilly +2 more
2009· review· en· Canadian Journal of Cardiology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
240
citations
fundno affunlabeled
Department of Error
2018· erratum· en· The Lancet· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
228
citations
affunlabeled
Valuations of EQ-5D Health States
Jeffrey Johnson, Nan Luo, James W. Shaw, Paul Kind, Stephen Joel Coons
2005· article· en· Medical Care· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
226
citations

How this was built: Screen · Findings · About